tiprankstipranks
Trending News
More News >
Genor Biopharma Holdings Limited (DE:67N0)
:67N0
Germany Market

Genor Biopharma Holdings Limited (67N0) Financial Statements

Compare
0 Followers

Genor Biopharma Holdings Limited Financial Overview

Genor Biopharma Holdings Limited's market cap is currently €154.53M. The company's EPS TTM is €-0.013; its P/E ratio is ―; Genor Biopharma Holdings Limited is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 206.23M¥ 0.00¥ 15.93M¥ 0.00¥ 10.33M
Gross Profit¥ 204.89M¥ 0.00¥ 14.95M¥ 0.00¥ 7.74M
Operating Income¥ -72.55M¥ -711.20M¥ -786.21M¥ -859.11M¥ -924.42M
EBITDA¥ -5.15M¥ -551.01M¥ -675.89M¥ -819.50M¥ -2.98B
Net Income¥ -51.28M¥ -674.36M¥ -730.40M¥ -865.37M¥ -3.03B
Balance Sheet
Cash & Short-Term Investments¥ 1.06B¥ 1.17B¥ 1.59B¥ 2.20B¥ 2.93B
Total Assets¥ 1.29B¥ 1.45B¥ 2.12B¥ 2.86B¥ 3.57B
Total Debt¥ 911.00K¥ 7.16M¥ 28.59M¥ 57.41M¥ 31.06M
Net Debt¥ -1.06B¥ -1.16B¥ -1.56B¥ -2.14B¥ -2.90B
Total Liabilities¥ 138.05M¥ 256.18M¥ 309.87M¥ 369.73M¥ 336.32M
Stockholders' Equity¥ 1.15B¥ 1.19B¥ 1.80B¥ 2.49B¥ 3.23B
Cash Flow
Free Cash Flow¥ -123.55M¥ -426.15M¥ -590.56M¥ -695.13M¥ -885.01M
Operating Cash Flow¥ -121.98M¥ -425.12M¥ -577.61M¥ -623.74M¥ -786.72M
Investing Cash Flow¥ 8.01M¥ 5.99M¥ -12.94M¥ -54.26M¥ -98.24M
Financing Cash Flow¥ -1.56M¥ -6.82M¥ -57.39M¥ 17.57M¥ 3.74B
Currency in CNY

Genor Biopharma Holdings Limited Earnings and Revenue History

Genor Biopharma Holdings Limited Debt to Assets

Genor Biopharma Holdings Limited Cash Flow

Genor Biopharma Holdings Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis